Back to Top
Biciromab Biosimilar - Research Grade
$710.00 - $6,900.00
Biciromab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
fibrin II beta chain
Concentration
5mg/ml
Isotype
Fab' - G1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
The beta chain of fibrin II is exposed upon clot formation, providing a thrombus-specific epitope studied in coagulation and imaging research. This product is an unconjugated, non-therapeutic analog of biciromab, supplied as a human Fab' (G1-kappa) recombinant fragment for research use only (RUO). It is formulated low in endotoxin to in vivo-suitable standards and manufactured in scalable milligram-to-gram quantities for high-throughput laboratories. Applications include functional and binding assays, fibrin- and thrombus-targeting studies, in vitro characterization and preclinical models of clot formation, with reliable consistency across lots.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













